Novartis, Amgen and Eli Lilly's Lp(a) Drugs Aim to Prevent Heart Attacks
Pharma believes it has found the next frontier in heart attack prevention. Novartis, amgen and Eli Lilly are among drugmakers…
amgen inc
Amazon launches GLP-1 weight loss program
Amazon GLP-1 Treatment Source: Amazon Inc. Amazon is delving into the burgeoning weight loss market, unveiling a new program Tuesday…
Trump prepares pharmaceutical tariffs of up to 100%
The Trump administration on Thursday imposed new tariffs on brand-name drugs from pharmaceutical companies that have not reached agreements with…
FDA approves high-dose version of Novo Nordisk's anti-obesity drug Wegovy
The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, on February…
FDA Vaccine Director to Resign in April After Series of Controversial Decisions
The Food and Drug Administration logo before a news conference at Health and Human Services Headquarters in Washington, April 22,…
Novo Nordisk Shares Fall as Weight Loss Drug Fails to Beat Eli Lilly
The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark, on Wednesday, November 5, 2025. Nichlas Pollier | Bloomberg | fake images…
White House launches direct-to-consumer drug site
President Donald Trump makes an announcement from the Oval Office of the White House in Washington, November 6, 2025. Jonathan…
Another Alliance Between Healthcare and AI Indicates Why Pharma Stocks Could Make a Comeback
Bristol Myers Squibb and Microsoft's new partnership aimed at accelerating the early detection of lung cancer marks the latest way…
Novo Nordisk CEO talks GLP-1 pill at JPMorgan conference
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
What to expect from the pharmaceutical industry at the JPM conference
Heidi Overton, Novo Nordisk CEO Maziar “Mike” Doustdar, Eli Lilly CEO David Ricks and Commerce Secretary Howard Lutnick listen as…